Please try another search
Ningbo Menovo Pharmaceutical Co., Ltd. research, develops, produces, and sells pharmaceutical products. The company’s products portfolio includes valsartan, losartan, clopidogrel, perindopril, rosuvastatin calcium, atorvastatin calcium, purin bahrain, and other products. It offers APIs, intermediates, and preparations for the treatment of cardiovascular, central nervous system, gastrointestinal tract, and other therapeutic areas. Ningbo Menovo Pharmaceutical Co., Ltd. was founded in 2004 and is headquartered in Ningbo, China.
Name | Age | Since | Title |
---|---|---|---|
Zi Min Ye | 52 | - | Independent Director |
Cheng Zhi Yao | 49 | - | GM & Chairman |
Lingna Shu | 35 | 2022 | Employee Supervisor |
Sibin Liu | 52 | 2021 | Supervisory Board Chairman |
Qian Cao | 41 | - | Director |
Hui Lin Li | 66 | - | Independent Director |
Xinmin Bao | 53 | - | Independent Director |
Gaofeng Ying | 52 | 2019 | Directo, CFO & Board Secretary |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review